Comparative efficacy and safety of weekly tirzepatide versus weekly insulin in type 2 diabetes: A network meta‐analysis of randomized clinical trials

Documenti analoghi

• Efficacy and safety of once‐weekly insulin icodec in type 2 diabetes: A meta‐analysis of ONWARDS phase 3 randomized controlled trials
  di: Sahana Shetty, et al.
  Pubblicazione: (2024)
• Efficacy and safety of once‐weekly basal insulin therapy in people with type 1 diabetes: A systematic review and meta‐analysis
  di: Ludovico Di Gioia, et al.
  Pubblicazione: (2025)
• Efficacy and safety of once‐weekly insulin icodec versus once‐daily basal insulin in Japanese individuals with type 2 diabetes: A subgroup analysis of the ONWARDS 1, 2 and 4 trials
  di: Hirotaka Watada, et al.
  Pubblicazione: (2024)
• Once‐weekly insulin icodec compared with daily basal insulin analogues in type 2 diabetes: Participant‐level meta‐analysis of the ONWARDS 1–5 trials
  di: Harpreet S. Bajaj, et al.
  Pubblicazione: (2024)
• Cost‐utility of once‐weekly insulin icodec versus once‐daily basal insulins for type 2 diabetes in China
  di: Xichen Tong, et al.
  Pubblicazione: (2026)